Modulation of hepatitis C virus replication by iron and hepcidin in Huh7 hepatocytes

Journal of General Virology

Volumn 92, Issue 9, 2011, Pages 2072-2081

  Bartolomei, Giody ^a,b   Cevik, Recep Emrah ^a   Marcello, Alessandro ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; FERRITIN; HEMIN; HEPCIDIN; IRON; MESSENGER RNA; STAT3 PROTEIN; VIRUS RNA;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; REPLICON; RNA INTERFERENCE; VIRUS REPLICATION;

ANTIMICROBIAL CATIONIC PEPTIDES; CELL LINE; HEPACIVIRUS; HEPATOCYTES; HUMANS; IRON; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 80051739560     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.032706-0     Document Type: Article

References (65)

1. Abboud, S. & Haile, D. J. (2000). A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275, 19906-19912.
2. Alter, M. J. (2007). Epidemiology of hepatitis C virus infection. World J Gastroenterol 13, 2436-2441.
3. Andriopoulos, B., Jr, Corradini, E., Xia, Y., Faasse, S. A., Chen, S., Grgurevic, L., Knutson, M. D., Pietrangelo, A., Vukicevic, S. & other authors (2009). BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 41, 482-487.
4. Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L. & other authors (2006). Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38, 531-539.
5. Bassett, S. E., Di Bisceglie, A. M., Bacon, B. R., Sharp, R. M., Govindarajan, S., Hubbard, G. B., Brasky, K. M. & Lanford, R. E. (1999). Effects of iron loading on pathogenicity in hepatitis C virusinfected chimpanzees. Hepatology 29, 1884-1892.
6. Bonkovsky, H. L. (2002). Iron as a comorbid factor in chronic viral hepatitis. Am J Gastroenterol 97, 1-4.
7. Bonkovsky, H. L., Naishadham, D., Lambrecht, R. W., Chung, R. T., Hoefs, J. C., Nash, S. R., Rogers, T. E., Banner, B. F., Sterling, R. K. & other authors (2006). Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C. Gastroenterology 131, 1440-1451.
8. Boucher, E., Bourienne, A., Adams, P., Turlin, B., Brissot, P. & Deugnier, Y. (1997). Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment. Gut 41, 115-120.
9. Cho, H., Lee, H. C., Jang, S. K. & Kim, Y. K. (2008). Iron increases translation initiation directed by internal ribosome entry site of hepatitis C virus. Virus Genes 37, 154-160.
10. Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W. & Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362.
11. De Marco, A., Dans, P. D., Knezevich, A., Maiuri, P., Pantano, S. & Marcello, A. (2010). Subcellular localization of the interaction between the human immunodeficiency virus transactivator Tat and the nucleosome assembly protein 1. Amino Acids 38, 1583-1593.
12. Desai, T. K., Jamil, L. H., Balasubramaniam, M., Koff, R. & Bonkovsky, H. L. (2008). Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials. Dig Dis Sci 53, 815-822.
13. Di Bisceglie, A. M., Axiotis, C. A., Hoofnagle, J. H. & Bacon, B. R. (1992). Measurements of iron status in patients with chronic hepatitis. Gastroenterology 102, 2108-2113.
14. Di Bona, D., Cippitelli, M., Fionda, C., Cammá, C., Licata, A., Santoni, A. & Craxi, A. (2006). Oxidative stress inhibits IFN-a-induced antiviral gene expression by blocking the JAK-STAT pathway. J Hepatol 45, 271-279.
15. Distante, S., Bjøro, K., Hellum, K. B., Myrvang, B., Berg, J. P., Skaug, K., Raknerud, N. & Bell, H. (2002). Raised serum ferritin predicts nonresponse to interferon and ribavirin treatment in patients with chronic hepatitis C infection. Liver 22, 269-275.
16. Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B. & other authors (2000). Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776-781.
17. Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Jr, Ellis, M. C. & other authors (1996). A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13, 399-408.
18. Fillebeen, C. & Pantopoulos, K. (2010). Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells. J Hepatol 53, 995-999.
19. Fillebeen, C. & Pantopoulos, K. (2011). Reply to: is there any association between HCV multiplication and iron induced liver injury in chronic hepatitis C? J Hepatol. doi:10.1016/j.jhep.2011.01.004.
20. Fillebeen, C., Rivas-Estilla, A. M., Bisaillon, M., Ponka, P., Muckenthaler, M., Hentze, M. W., Koromilas, A. E. & Pantopoulos, K. (2005). Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C Virus. J Biol Chem 280, 9049-9057.
21. Fillebeen, C., Muckenthaler, M., Andriopoulos, B., Bisaillon, M., Mounir, Z., Hentze, M. W., Koromilas, A. E. & Pantopoulos, K. (2007). Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells. J Hepatol 47, 12-22.
22. Fleming, M. D., Trenor, C. C., III, Su, M. A., Foernzler, D., Beier, D. R., Dietrich, W. F. & Andrews, N. C. (1997). Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 16, 383-386.
23. Franchini, M., Targher, G., Capra, F., Montagnana, M. & Lippi, G. (2008). The effect of iron depletion on chronic hepatitis C virus infection. Hepatol Int 2, 335-340.
24. Fujita, N., Sugimoto, R., Urawa, N., Araki, J., Mifuji, R., Yamamoto, M., Horiike, S., Tanaka, H., Iwasa, M. & other authors (2007). Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C. J Gastroenterol Hepatol 22, 1886-1893.
25. Fujita, N., Sugimoto, R., Motonishi, S., Tomosugi, N., Tanaka, H., Takeo, M., Iwasa, M., Kobayashi, Y., Hayashi, H. & Kaito, M. (2008). Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion. J Hepatol 49, 702-710.
26. Ganz, T. (2006). Hepcidin - a peptide hormone at the interface of innate immunity and iron metabolism. Curr Top Microbiol Immunol 306, 183-198.
27. Hentze, M. W., Muckenthaler, M. U. & Andrews, N. C. (2004). Balancing acts: molecular control of mammalian iron metabolism. Cell 117, 285-297.
28. Hoenninger, V. M., Rouha, H., Orlinger, K. K., Miorin, L., Marcello, A., Kofler, R. M. & Mandl, C. W. (2008). Analysis of the effects of alterations in the tick-borne encephalitis virus 39-noncoding region on translation and RNA replication using reporter replicons. Virology 377, 419-430.
29. Hou, W. H., Rossi, L., Shan, Y., Zheng, J. Y., Lambrecht, R. W. & Bonkovsky, H. L. (2009). Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells. World J Gastroenterol 15, 4499-4510.
30. Hou, W., Tian, Q., Zheng, J. & Bonkovsky, H. L. (2010). Zinc mesoporphyrin induces rapid proteasomal degradation of hepatitis C nonstructural 5A protein in human hepatoma cells. Gastroenterology 138, 1909-1919.e3.
31. Indraccolo, S., Pfeffer, U., Minuzzo, S., Esposito, G., Roni, V., Mandruzzato, S., Ferrari, N., Anfosso, L., Dell'Eva, R. & other authors (2007). Identification of genes selectively regulated by IFNs in endothelial cells. J Immunol 178, 1122-1135.
32. Kato, T., Date, T., Miyamoto, M., Sugiyama, M., Tanaka, Y., Orito, E., Ohno, T., Sugihara, K., Hasegawa, I. & other authors (2005). Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system. J Clin Microbiol 43, 5679-5684.
33. Kato, T., Date, T., Murayama, A., Morikawa, K., Akazawa, D. & Wakita, T. (2006). Cell culture and infection system for hepatitis C virus. Nat Protoc 1, 2334-2339.
34. Koutsoudakis, G., Kaul, A., Steinmann, E., Kallis, S., Lohmann, V., Pietschmann, T. & Bartenschlager, R. (2006). Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J Virol 80, 5308-5320.
35. Lambrecht, R. W., Sterling, R. K., Naishadham, D., Stoddard, A. M., Rogers, T., Morishima, C., Morgan, T. R., Bonkovsky, H. L. & HALT-C Trial Group (2011). Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C. Gastroenterology 140, 1490-1500.e3.
36. Lauer, G. M. & Walker, B. D. (2001). Hepatitis C virus infection. N Engl J Med 345, 41-52.
37. Lin, C. C. & Yin, M. C. (2008). Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin. Clin Nutr 28, 34-38.
38. McKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J. & other authors (2000). A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5, 299-309.
39. Miorin, L., Maiuri, P., Hoenninger, V. M., Mandl, C. W. & Marcello, A. (2008). Spatial and temporal organization of tick-borne encephalitis flavivirus replicated RNA in living cells. Virology 379, 64-77.
40. Miura, K., Taura, K., Kodama, Y., Schnabl, B. & Brenner, D. A. (2008). Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 48, 1420-1429.
41. Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A. & Ganz, T. (2003). Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101, 2461-2463.
42. Nishina, S., Hino, K., Korenaga, M., Vecchi, C., Pietrangelo, A., Mizukami, Y., Furutani, T., Sakai, A., Okuda, M. & other authors (2008). Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology 134, 226-238.
43. Olynyk, J. K., Reddy, K. R., Di Bisceglie, A. M., Jeffers, L. J., Parker, T. I., Radick, J. L., Schiff, E. R. & Bacon, B. R. (1995). Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 108, 1104-1109.
44. Paeshuyse, J., Coelmont, L., Vliegen, I., Van hemel, J., Vandenkerckhove, J., Peys, E., Sas, B., De Clercq, E. & Neyts, J. (2006). Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisinin. Biochem Biophys Res Commun 348, 139-144.
45. Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L., Franchini, P. L., Dubé, M. P., Andres, L., MacFarlane, J., Sakellaropoulos, N. & other authors (2004). Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36, 77-82.
46. Pegoraro, G., Marcello, A., Myers, M. P. & Giacca, M. (2006). Regulation of adeno-associated virus DNA replication by the cellular TAF-I/set complex. J Virol 80, 6855-6864.
47. Pietrangelo, A. (2003). Hemochromatosis gene modifies course of hepatitis C viral infection. Gastroenterology 124, 1509-1523.
48. Shan, Y., Lambrecht, R. W., Donohue, S. E. & Bonkovsky, H. L. (2006). Role of Bach1 and Nrf2 in up-regulation of the heme oxygenase-1 gene by cobalt protoporphyrin. FASEB J 20, 2651-2653.
49. Shan, Y., Zheng, J., Lambrecht, R. W. & Bonkovsky, H. L. (2007). Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology 133, 1166-1174.
50. Sherrington, C. A. & Olynyk, J. K. (2002). Iron as a cofactor in chronic hepatitis C infection. Liver 22, 187-189.
51. Sikorska, K., Stalke, P. & Bielawski, K. P. (2011). Is there any association between HCV multiplication and iron induced liver injury in chronic hepatitis C? J Hepatol.
52. Sklan, E. H., Charuworn, P., Pang, P. S. & Glenn, J. S. (2009). Mechanisms of HCV survival in the host. Nat Rev Gastroenterol Hepatol 6, 217-227.
53. Souza, R. M., Freitas, L. A., Lyra, A. C., Moraes, C. F., Braga, E. L. & Lyra, L. G. (2006). Effect of iron overload on the severity of liver histologic alterations and on the response to interferon and ribavirin therapy of patients with hepatitis C infection. Braz J Med Biol Res 39, 79-83.
54. Tai, A. W., Benita, Y., Peng, L. F., Kim, S. S., Sakamoto, N., Xavier, R. J. & Chung, R. T. (2009). A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 5, 298-307.
55. Tenhunen, R., Tokola, O. & Lindén, I. B. (1987). Haem arginate: a new stable haem compound. J Pharm Pharmacol 39, 780-786.
56. Theurl, I., Zoller, H., Obrist, P., Datz, C., Bachmann, F., Elliott, R. M. & Weiss, G. (2004). Iron regulates hepatitis C virus translation via stimulation of expression of translation initiation factor 3. J Infect Dis 190, 819-825.
57. Torti, F. M. & Torti, S. V. (2002). Regulation of ferritin genes and protein. Blood 99, 3505-3516.
58. Van Thiel, D. H., Friedlander, L., Fagiuoli, S., Wright, H. I., Irish, W. & Gavaler, J. S. (1994). Response to interferon a therapy is influenced by the iron content of the liver. J Hepatol 20, 410-415.
59. Vardabasso, C., Manganaro, L., Lusic, M., Marcello, A. & Giacca, M. (2008). The histone chaperone protein nucleosome assembly protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcription. Retrovirology 5, 8.
60. Verga Falzacappa, M. V., Vujic Spasic, M., Kessler, R., Stolte, J., Hentze, M. W. & Muckenthaler, M. U. (2007). STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109, 353-358.
61. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H. G. & other authors (2005). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11, 791-796.
62. Walker, E. M., Jr & Walker, S. M. (2000). Effects of iron overload on the immune system. Ann Clin Lab Sci 30, 354-365.
63. Yang, C. H., Wei, L., Pfeffer, S. R., Du, Z., Murti, A., Valentine, W. J., Zheng, Y. & Pfeffer, L. M. (2007). Identification of CXCL11 as a STAT3-dependent gene induced by IFN. J Immunol 178, 986-992.
64. Zhu, H., Zhao, H., Collins, C. D., Eckenrode, S. E., Run, Q., McIndoe, R. A., Crawford, J. M., Nelson, D. R., She, J. X. & Liu, C. (2003). Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology 37, 1180-1188.
65. Zhu, H., Shang, X., Terada, N. & Liu, C. (2004). STAT3 induces antihepatitis C viral activity in liver cells. Biochem Biophys Res Commun 324, 518-528.